Clinical Trial Update: Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients [Phase 2]

View source ↗

Summary

Phase 2 pilot study assessing efficacy and tolerability of a fish oil emulsion combined with daunorubicin and cytarabine in younger patients with acute myeloid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Fish oil emulsion (fish oil emulsion)

Snippet

Sponsor: French Innovative Leukemia Organisation | Conditions: Acute Myeloid Leukemia (AML) | Phase 2 | Status: COMPLETED